| Bioactivity | Valbenazine (NBI-98854) dihydrochloride is a VMAT2 inhibitor, used to treat tardive dyskinesia. Valbenazine dihydrochloride demonstrates potential benefit in alleviating symptoms associated with movement disorders resulting from chronic dopamine receptor blocking medications. Valbenazine dihydrochloride has been supported by evidence from preclinical models examining its role in the genetic factors linked to tardive dyskinesia. |
| CAS | 1639208-51-7 |
| Formula | C24H40Cl2N2O4 |
| Molar Mass | 491.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Genetics of tardive dyskinesia: Promising leads and ways forward |
Valbenazine dihydrochloride
CAS: 1639208-51-7 F: C24H40Cl2N2O4 W: 491.49
Valbenazine (NBI-98854) dihydrochloride is a VMAT2 inhibitor, used to treat tardive dyskinesia. Valbenazine dihydrochlor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.